Anne Lazareth

565 total citations
13 papers, 88 citations indexed

About

Anne Lazareth is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Anne Lazareth has authored 13 papers receiving a total of 88 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 5 papers in Genetics and 5 papers in Oncology. Recurrent topics in Anne Lazareth's work include Multiple Myeloma Research and Treatments (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Anne Lazareth is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Anne Lazareth collaborates with scholars based in France, New Caledonia and United States. Anne Lazareth's co-authors include Jean Charles Soria, Emmanuel Bachy, Benjamin Besse, Lionel Karlin, Hervé Ghesquières, Hassane Izzedine, Edward Bourry, Jérémie Tordo, Thierry Fest and Éric Bellissant and has published in prestigious journals such as Blood, PLoS ONE and Kidney International.

In The Last Decade

Anne Lazareth

13 papers receiving 87 citations

Peers

Anne Lazareth
Guido Ghilardi United States
Zsolt Nagy Hungary
Francisco Bracho United States
Razeen Mahroof United Kingdom
Guido Ghilardi United States
Anne Lazareth
Citations per year, relative to Anne Lazareth Anne Lazareth (= 1×) peers Guido Ghilardi

Countries citing papers authored by Anne Lazareth

Since Specialization
Citations

This map shows the geographic impact of Anne Lazareth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Lazareth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Lazareth more than expected).

Fields of papers citing papers by Anne Lazareth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Lazareth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Lazareth. The network helps show where Anne Lazareth may publish in the future.

Co-authorship network of co-authors of Anne Lazareth

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Lazareth. A scholar is included among the top collaborators of Anne Lazareth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Lazareth. Anne Lazareth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Cordeil, Stéphanie, Estelle Bourbon, Emmanuelle Ferrant, et al.. (2022). Flare-up phenomenon or pseudoprogression after CAR T-cell infusion in non-Hodgkin aggressive lymphomas. Leukemia & lymphoma. 64(3). 707–711. 9 indexed citations
2.
Karlin, Lionel, Anne Baudouin, Aurore Gouraud, et al.. (2021). Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study. Journal of Cancer Research and Clinical Oncology. 148(4). 975–984. 12 indexed citations
4.
Ranchon, Florence, Laure Huot, Isabelle Carpentier, et al.. (2020). Immunomodulatory drugs in multiple myeloma: Impact of the SCARMET (Self CARe and MEdication Toxicity) educational intervention on outpatients’ knowledge to manage adverse effects. PLoS ONE. 15(12). e0243309–e0243309. 4 indexed citations
5.
Rousset, Pascal, et al.. (2019). Acute Renal Colic Due to Immunoglobulin Free Light Chain Kidney Stones: A Case Report of an Unusual Complication of Multiple Myeloma. American Journal of Kidney Diseases. 74(5). 700–702. 3 indexed citations
7.
Tartas, Sophie, et al.. (2018). Pure Seminoma and Concurrent Aggressive Lymphoma: Case Report of a Patient With Persistent Müllerian Duct Syndrome. Clinical Genitourinary Cancer. 17(2). e369–e371. 2 indexed citations
8.
Maucort‐Boulch, Delphine, Estelle Bourbon, Lionel Karlin, et al.. (2018). Refractory diffuse large B‐cell lymphoma after first‐line immuno‐CT: Treatment options and outcomes. Hematological Oncology. 36(3). 533–542. 2 indexed citations
9.
Szalat, Raphaël, Gentiane Monsel, Wilfried Le Goff, et al.. (2015). The spectrum of neutrophilic dermatoses associated with monoclonal gammopathy: Association with IgA isotype and inflammatory profile. Journal of the American Academy of Dermatology. 73(5). 809–820. 19 indexed citations
10.
Jaccard, Arnaud, Anne Lazareth, Lionel Karlin, et al.. (2014). A Prospective Phase II Trial of Lenalidomide and Dexamethasone ( LEN-DEX) in POEMS Syndrome. Blood. 124(21). 36–36. 8 indexed citations
11.
Arnulf, Bertrand, Anne Lazareth, Jean Soulier, et al.. (2012). Prognostic Value of the Different MMSET Gene Breakpoints and Correlation with Immunoglobulin Isotype and FGFR3 Expression in 173 Patients with t(4;14) Multiple Myeloma. Blood. 120(21). 3971–3971. 1 indexed citations
12.
Izzedine, Hassane, Benjamin Besse, Anne Lazareth, Edward Bourry, & Jean Charles Soria. (2008). Hypokalemia, metabolic alkalosis, and hypertension in a lung cancer patient. Kidney International. 76(1). 115–120. 10 indexed citations
13.
Duron, Emmanuelle, et al.. (2008). Gliomatosis cerebri presenting as rapidly progressive dementia and parkinsonism in an elderly woman: a case report. Journal of Medical Case Reports. 2(1). 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026